...
首页> 外文期刊>Molecular Genetics and Metabolism Reports >The factors affecting lipid profile in adult patients with Mucopolysaccharidosis
【24h】

The factors affecting lipid profile in adult patients with Mucopolysaccharidosis

机译:成年黏多糖贮积症患者脂质分布的影响因素

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Mucopolysaccharidoses (MPS) are a group of rare inherited disorders characterized by abnormal accumulation of glycosaminoglycans (GAGs) within the myocytes and coronary arteries. Little is known about hyperlipidaemia as a potential cardiovascular risk factor in these patients. Baseline cholesterol data in adults are scarce. Therefore, the aim of this study was to analyse factors affecting lipid profile in different types of MPSs to determine if abnormalities in lipid profile contribute to the overall risk of cardiovascular disease. Methods Adult patients (above the age of 16) with MPS type I, II, III, IV and VI attending clinics in two Inherited Metabolic Disorders centres were included. Their lipid profile, lipoprotein (a), HbA1c, Glucose Tolerance Test (GTT), BMI and treatment type were extracted. Analysis included descriptive statistics and Student t -test. Results Eighty two patients with five MPS types (I, II, III, IV and VI) were included in the study; 29 were females (35%) and 53 were males (65%). BMI above 25 kg/m2 in all MPS types indicated that some patients were overweight for their height. Only one patient post-HSCT had diabetes. In 3 cases insulin was analysed during GTT and showed no insulin resistance despite raised BMI. Mean total cholesterol and LDL-cholesterol were below 5 mmol/L and 3 mmol/L, respectively, in five individual MPS types. Lipoprotein (a) was available for 6 MPS IV patients and was not significantly raised. Conclusions MPS disorders are not associated with significant hypercholesterolaemia or diabetes mellitus despite increased BMI. Total cholesterol and LDL-cholesterol were within the targets for primary prevention for non-MPS population. Lipoprotein (a) is not a useful marker of cardiovascular disease in a small group of adult MPS IV patients irrespectively of treatment option. Whether long-term cardiovascular risk is dependent on lipid profile, diabetes, obesity or GAGs deposition within the organ system remains unanswered.
机译:背景粘多糖贮积酶(MPS)是一组罕见的遗传性疾病,其特征是在肌细胞和冠状动脉内糖胺聚糖(GAG)的异常蓄积。关于高脂血症作为这些患者中潜在的心血管危险因素知之甚少。成人的基线胆固醇数据很少。因此,本研究的目的是分析影响不同类型MPS中脂质谱的因素,以确定脂质谱异常是否有助于心血管疾病的总体风险。方法包括在两个遗传代谢疾病中心就诊的16岁以上MPS I,II,III,IV和VI型成年患者。提取他们的脂质概况,脂蛋白(a),HbA1c,葡萄糖耐量试验(GTT),BMI和治疗类型。分析包括描述性统计和学生t检验。结果本研究共纳入82例五种MPS类型(I,II,III,IV和VI)。女性为29名(35%),男性为53名(65%)。所有MPS类型的BMI均高于25 kg / m 2 表明某些患者的身高超重。 HSCT后只有一名患者患有糖尿病。在3例中,在GTT期间对胰岛素进行了分析,尽管BMI升高,但未显示胰岛素抵抗。在五种单独的MPS类型中,平均总胆固醇和LDL-胆固醇分别低于5 mmol / L和3 mmol / L。脂蛋白(a)可用于6名MPS IV患者,但并未显着升高。结论尽管BMI升高,但MPS障碍与显着的高胆固醇血症或糖尿病无关。总胆固醇和低密度脂蛋白胆固醇在非MPS人群一级预防的目标之内。脂蛋白(a)在少数成年MPS IV成人患者中不是心血管疾病的有用标志物,与治疗方案无关。长期的心血管风险是否取决于脂质分布,糖尿病,肥胖症或器官系统内GAG的沉积尚无定论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号